Praxis Precision Medicines
PRAX
278.02
-2.12
-0.76%
Praxis Precision Medicines
US · PRAX
#1645 by market cap
Listed 2020
278.02
-2.12
-0.76%
Live - 5344 symbols - heartbeat 476s ago
· 2026-10-08 04:00
Pre-market
278.02
0.00%
After-hours
280.00
+0.71%
Overnight
276.72
-0.47%
- Market cap
- 7.76B
- P/E (TTM)i
- -21.45
- P/Bi
- 5.79
- EPSi
- -13.48
- Div yieldi
- 0.00%
- 52W posi
- 66%
Reader sentiment
Are you bullish or bearish on PRAX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- Total institutional ownership rose 0.2 percentage points.
Institutional ownership
- Held by institutions
- 122.52% +0.19pp
- Institutions
- 377
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund78.93%
Hedge Fund23.46%
VC/PE Fund9.45%
Public Company6.82%
Government Pension Fund1.35%
Sovereign Wealth Fund1.25%
Private Company1.04%
Individual/Insider0.19%
Insurance Company0.18%
Top holders as of 2026-06-30
Janus Henderson Group plc
12.25% · 3.42M sh
FMR
8.29% · 2.32M sh
BlackRock
8.21% · 2.29M sh
Perceptive Advisors LLC
7.29% · 2.04M sh
Baker Bros. Advisors LP
6.28% · 1.75M sh
Orbis Investment Management Limited
5.48% · 1.53M sh
Vanguard Capital Management, LLC
5.10% · 1.42M sh
Vanguard Portfolio Management, LLC
4.78% · 1.34M sh
T. Rowe Price Group, Inc.
3.95% · 1.10M sh
State Street Global Advisors
3.68% · 1.03M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 35 buys · 15 sells
| Name | Role | Stake |
|---|---|---|
| Dean Mitchell | Independent Chairperson | 0.06% |
| Timothy Kelly | Chief Financial Officer | 0.03% |
| Alex Nemiroff | General Counsel | 0.02% |
| Megan Sniecinski | Chief Business Officer | 0.02% |
| Lauren Mastrocola | VP of Finance & Principal Accounting Officer | 0.01% |
| Jill DeSimone | Independent Director | 0.01% |
| William Young | Independent Director | 0.01% |
| Marcio De'Souza | Chief Executive Officer | 0.00% |
| Jeffrey Kindler | Director | 0.00% |
| Stuart Arbuckle | Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-07 | Marcio De'Souza | Chief Executive Officer | Other Disposition | -23,121 | -- |
| 2026-06-23 | Jill DeSimone | Independent Director | Derivative Exercise and Sale | -11,600 | $44.25–315.71 |
| 2026-06-09 | William Young | Independent Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | William Young | Independent Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Jeffrey Kindler | Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Jeffrey Kindler | Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Dean Mitchell | Independent Chairperson | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Dean Mitchell | Independent Chairperson | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Gregory Norden | Independent Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Gregory Norden | Independent Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Merit Cudkowicz | Independent Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Merit Cudkowicz | Independent Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Stuart Arbuckle | Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Stuart Arbuckle | Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Jill DeSimone | Independent Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Jill DeSimone | Independent Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-06-09 | Jeffrey Chodakewitz | Independent Director | Other Acquisition | +1,371 | -- |
| 2026-06-09 | Jeffrey Chodakewitz | Independent Director | Other Derivative Acquisition | +648 | $240.66 |
| 2026-05-13 | Alex Nemiroff | General Counsel | Other Acquisition | +78 | $167.94 |
| 2026-05-13 | Marcio De'Souza | Chief Executive Officer | Other Acquisition | +126 | $167.94 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 04:00:01 · For reference only, not investment advice and not tailored to your situation.